We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE. In this ...

The rising cost of prescription medications in the U.S. is a serious issue, particularly for those needing life-saving ...

The family eventually found that medication. Later, two others Abby needed were hard to find. The Brays, like thousands of ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Akero Therapeutics (NASDAQ:AKRO) is a biotechnology company that is developing a treatment for Metabolic ...

Madrigal Pharmaceuticals (NASDAQ:MDGL) is a clinical-stage biopharmaceutical company specializing in developing therapies for ...

Ahead of the November general election, the Southern California News Group compiled a list of questions to pose to the ...

If you're over 65 years old, there is a 1 in 4 chance you are navigating a mental health condition, according to the National Council on Aging, and an even higher chance you're enrolled in Medicare.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Metformin, a chemical relative of that compound, has been a top type 2 diabetes treatment in the United States since it was approved in 1994. It’s cheap—less than a dollar per dose—and readily ...

Because the commonly-used chemotherapy drug carboplatin was in short supply ... by imposing changes such as banning PBMs from receiving payment based on the list price of a drug in Medicare and ...